Citigroup’s Global X Scientific Beta Europe ETF SCID Stock Holding History

Citigroup’s Portfolio SCID Stock Details SCID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-450,000	Closed	-$12.8M	–	7714
2017 Q3	$12.8M	Hold	450,000	–	–	0.01%	1074
2017 Q2	$12M	Hold	450,000	–	–	0.01%	1030
2017 Q1	$10.9M	Hold	450,000	–	–	0.01%	1083
2016 Q4	$9.99M	Hold	450,000	–	–	0.01%	1192
2016 Q3	$10.7M	Hold	450,000	–	–	0.01%	1033
2016 Q2	$10.1M	Hold	450,000	–	–	0.01%	1035
2016 Q1	$10.7M	Buy	+450,000	New	+$10M	0.01%	965

Other funds holding SCID

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup's SCID Position: Q4 2017 in Review

Citigroup sold out of Global X Scientific Beta Europe ETF (SCID) in Q4 2017, closing a stake of 450,000 shares — an estimated $12.8M sold.

Citigroup first reported a position in SCID in Q1 2016 and held it in 7 quarters. The position peaked at $12.8M in Q3 2017. 4 funds tracked by Wall St. Rank hold SCID as of Q4 2017.

Citigroup reported no remaining Global X Scientific Beta Europe ETF position as of Q4 2017 after selling out during the quarter.
Citigroup sold 450,000 Global X Scientific Beta Europe ETF shares in Q4 2017, an estimated $12.8M.
Citigroup first reported a position in Global X Scientific Beta Europe ETF in Q1 2016 and held it in 7 quarters.
Citigroup's Global X Scientific Beta Europe ETF position peaked at $12.8M in Q3 2017.
4 funds tracked by Wall St. Rank held Global X Scientific Beta Europe ETF as of Q4 2017.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.